Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Recruiting × cc-486 × Clear all

Phase

Status

Completed 7 Terminated 3 Active not recruiting 2 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

pembrolizumab 206 Carboplatin 190 Specimen Handling 171 Cisplatin 169 Magnetic Resonance Spectroscopy 149 Radiotherapy 128 Bevacizumab 121 Gemcitabine 112 Cyclophosphamide 110 Drug Therapy 104 Capecitabine 100 Paclitaxel 97 venetoclax 96 Nivolumab 95 Oxaliplatin 86 Biopsy 86 durvalumab 74 tislelizumab 72 Rituximab 72 Etoposide 62 toripalimab 61 Radiosurgery 61 atezolizumab 60 Fluorouracil 60 Docetaxel 60 Pemetrexed 58 Dexamethasone 56 Azacitidine 54 lenvatinib 53 sintilimab 50

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06022003 2025-03-24

OGILAR

French Innovative Leukemia Organisation

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡